Doctor profile · Federal record
Dr. Richard White, M.D.
Hematology & Oncology Physician (CMS: Medical Oncology) · Specialist · Mountain Home, AR
- NPI 1700840980
- Accepts Medicare
- 40 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
639 Hospital Dr
Mountain Home, AR 726532914
(479) 587-1700
fax (479) 587-1366
Credentials & registration
- NPI registered
- April 2006 — 20 yrs on file
- Profile last updated
- January 31, 2024
- Year of graduation
- 1986 — 40 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State licenses (2)
- Arkansas #C7166 · Arkansas #C-7166
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1700840980. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
140,977
Distinct HCPCS
10
Medicare allowed
$2,823,844
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 30,600 | 45 | $0 | |
J9271 |
Injection, pembrolizumab, 1 mg | 18,400 | 33 | $55 | |
Q5110 |
Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram | 13,560 | 13 | $0 | |
J9144 |
Injection, daratumumab, 10 mg and hyaluronidase-fihj | 12,240 | 14 | $48 | |
J9299 |
Injection, nivolumab, 1 mg | 11,800 | 12 | $30 | |
J9264 |
Injection, paclitaxel protein-bound particles, 1 mg | 9,300 | 11 | $13 | |
J0897 |
Injection, denosumab, 1 mg | 7,440 | 41 | $24 | |
J9267 |
Injection, paclitaxel, 1 mg | 6,255 | 14 | $0 | |
J1453 |
Injection, fosaprepitant, 1 mg | 5,850 | 15 | $0 | |
Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 3,475 | 35 | $0 |
In context: peer comparison
Among 5 peers in this city , average services per provider: 1,521. This provider delivers 93× the peer median.Open Payments
Industry payments received
All-time total
$400
Transactions
25
Manufacturers
13
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. | 4 | $59.62 | |
| Rigel Pharmaceuticals, Inc. | 3 | $45.22 | |
| Novartis Pharmaceuticals Corporation | 3 | $44.38 | |
| ABBVIE INC. | 2 | $42.43 | |
| Daiichi Sankyo Inc. | 2 | $38.89 | |
| Eisai Inc. | 2 | $33.06 | |
| PFIZER INC. | 2 | $26.45 | |
| JAZZ PHARMACEUTICALS INC. | 2 | $26.33 | |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22.80 | |
| ADC Therapeutics America, Inc. | 1 | $17.40 | |
| Genmab U.S., Inc. | 1 | $14.98 | |
| Pharmacosmos Therapeutics Inc. | 1 | $14.75 | |
| AstraZeneca Pharmaceuticals LP | 1 | $13.39 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,023
Patients
294
Total drug cost
$567,852
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 345 | 94 | $9,554 |
| Oxycodone Hcl | Generic | 114 | 22 | $2,523 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 82 | 31 | $2,506 |
| Hydroxyurea | Generic | 78 | 18 | $1,905 |
| Ondansetron Hcl | Generic | 49 | 28 | $4,295 |
| Imatinib Mesylate | Generic | 48 | 0 | $66,676 |
| Ondansetron Odt (Ondansetron) | Brand | 47 | 28 | $2,294 |
| Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen) | Brand | 44 | 0 | $1,318 |
| Fentanyl | Generic | 38 | 12 | $8,531 |
| Acyclovir | Generic | 35 | 13 | $653 |
Hospital affiliations
Frequently asked questions
What is Dr. Richard White's medical specialty?
Dr. Richard White practices Hematology & Oncology Physician in Mountain Home, AR.
Where does Dr. Richard White practice?
Dr. Richard White practices at 639 Hospital Dr, Mountain Home, AR 726532914. Office phone: 4795871700.
What is Dr. Richard White's NPI?
Dr. Richard White's National Provider Identifier (NPI) is 1700840980, issued by NPPES.
Does Dr. Richard White accept Medicare assignment?
Yes. Dr. Richard White accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Richard White commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS Q0138); Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram (HCPCS Q5110). Source: CMS Medicare Physician & Other Practitioners file.